BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Cord Blood » Page 55

Cord Blood

Because cord blood present within a newborn’s umbilical is rich with stem cells, it can be collected and stored for future medical use.

Save the Cord Foundation and BioInformant Join Forces in Global Effort to Increase Cord Blood Banking Awareness

April 1, 2015 By Cade Hildreth (CEO) Leave a Comment

Save the Cord Foundation and BioInformant Announce Partnership for Cord Blood Banking Awareness

PRESS RELEASE; April 1, 2015
WASHINGTON, DC, and TUCSON, AZ

Press release available at PR Web:  http://www.prweb.com/releases/2015/04/prweb12627399.htm.

For expectant parents, there are thousands of decisions to make in a short amount of time, including clothes, cribs, names, birthing methods, medical procedures, and more. It can be overwhelming, especially given the short-time frame involved. In addition to these decisions, there is an often overlooked decision: what to do with the extremely valuable stem and progenitor cells contained within the umbilical cord of the expected newborn? There are three options, which are to publicly donate, to privately store, or to discard the umbilical cord as medical waste. Two of those decisions require research and action on behalf of the parents, while the third is what happens when sufficient awareness and education has not been provided to allow parents to make an informed, educated decision. [Read more…]

Filed Under: Cord Blood, HSCs, MSCs Tagged With: awareness, campaign, collaboration, cord blood, hematopoietic stem cells, mesenchymal stem cells, partnership, save the cord

MarketResearch.com: “Blockbuster” Year for Stem Cells Creates Market Opportunities

April 1, 2015 By Cade Hildreth (CEO) Leave a Comment

Stem Cell and Cord Blood Market Trends
PRESS RELEASE

WASHINGTON and NEW YORK CITY and LONDON, April 1, 2015 /PRNewswire/ — As a leading provider of market research reports and solutions, MarketResearch.com is pleased to highlight a report by BioInformant Worldwide, LLC, indicating that 2015 will be a year of market growth and opportunity for the stem cell industry.

For executives operating a stem cell company or cord blood bank, competing in the stem cell marketplace is a difficult task. You must analyze market conditions, predict industry trends, and act on market changes before the competition. [Read more…]

Filed Under: Cord Blood, Stem Cells Tagged With: analysis, cord blood, market research, projections, stem cells, strategy, trends

WideCells – Stem Cell Biotechnology and Regenerative Medicine in the 21st Century

March 31, 2015 By Cade Hildreth (CEO) Leave a Comment

WideCells – Stem Cell Biotechnology and Regenerative Medicine in the 21st Century

WideCells is a new and innovative stem cell technology and regenerative medicine company. It was founded by the CEO João Andrade and the CFO Lopes Gil. Dr Peter Hollands later joined as CSO bringing experience from other UK and international stem cell banks, clinical transplantation, teaching and research.

The first operations for WideCells were in Portugal, following on to the acquisition of the Spanish company Nacersalud to begin operations in Spain.

The continued success of operations in Portugal and Spain has led to the development of [Read more…]

Filed Under: Cord Blood, Stem Cells Tagged With: clinical transplantation, cord blood banking, mesenchymal stem cells, regenerative medicine, stem cell banking, stem cells, widecells

Case Law & Legal Updates for the Cord Blood Banking Market

March 16, 2015 By Cade Hildreth (CEO) Leave a Comment

Cord Blood Banking Case Law

Major Cord Blood Industry Change in 2015

Although we are only a few months into 2015, the cord blood banking market has already been experiencing rapid change.

The industry has seen structural advances occur, including a recent announcement of the Board of Directors for the Cord Blood Association, an  international nonprofit  that  promotes the  storage and use of cord blood and related tissues, such as cord tissue and placenta.

There have been major research advances as well. In one major example, a porcine animal study was conducted by the Mayo Clinic to evaluate the safety and feasibility of  cord blood-derived mononuclear cells (UBC-MNC) for use in promoting regeneration in pediatric congenital heart disease (CHD).

There have even been major clinical advances made already in 2015, with CryoSave leading and sponsoring a multicentre clinical trial following GCP-ICH standards, to determine if Cerebral Palsy can be addressed by infusing stem cells derived from umbilical cord blood and cord tissue into patients.

However, no understanding of the cord blood market is complete without a consideration of recent case law and significant legal decisions, which brings us to the focus on this market update.

Cord Blood Case Law & Legal Updates

Currently, there are three legal situations of which cord blood market participants should be aware: [Read more…]

Filed Under: Cord Blood, HSCs Tagged With: case law, cord blood, court, hematopoietic stem cells, industry news, legal

Geographical Breakdown Of AABB Accredited Cord Blood Banks

March 14, 2015 By Cade Hildreth (CEO) Leave a Comment

Cord Bloods | Geographical Breakdown of AABB Accredited Cord Blood Banks

Within the United States, cord blood banks are subject to federal and state regulations and all cord blood banks must be registered with the U.S. FDA. The FDA governs all aspects of cord blood preservation, including the collection, processing, storage, labeling, packaging, and distribution of cord blood stem cells. In addition, there are a number of other agencies that accredit cord blood banks, including the AABB, Foundation for the Accreditation of Cellular Therapy (FACT), Clinical Laboratory Improvement Amendments (CLIA), and more.
[Read more…]

Filed Under: Cord Blood

  • « Previous Page
  • 1
  • …
  • 53
  • 54
  • 55
  • 56
  • 57
  • Next Page »

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97

Featured Posts

Cord Blood Market Segmentation

Cord Blood Market Segmentation – Biobanking, HSCT, Cellular Therapy, Genetic Manipulation, & Research Tools

CAR-T Companies

CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide

Who discovered stem cells?

Who Discovered Stem Cells? The Answers Revealed

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.